3-D Matrix, Ltd. develops self-assembling peptide technology in Japan and internationally. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the regenerative medicine, cell therapy, drug delivery systems, and other uses in various fields. The company was incorporated in 2004 and is based in Tokyo, Japan.
Stock data | 2023 | Change |
---|---|---|
Price | $0.8662311843226356 | N/A |
Market Cap | $52.14M | N/A |
Shares Outstanding | 60.19M | 18.18% |
Employees | 108.00 | N/A |
Shareholder Equity | 524.77M | -64.00% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | -0.02 | N/A |
P/S Ratio | 3.17 | N/A |
P/B Ratio | 0.10 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | -0.0331 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $16.43M | N/A |
Earnings | -$17.37M | N/A |
EPS | -40.64 | N/A |
Earnings Yield | -46.92 | N/A |
Gross Margin | 0.5567 | N/A |
Operating Margin | -1.36 | N/A |
Net income margin | -1.06 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $41.36M | N/A |
Total Debt | $31.06M | N/A |
Cash on Hand | $8.31M | N/A |
Debt to Equity | 0.0717 | 254.55% |
Cash to Debt | 0.2677 | -65.56% |
Current Ratio | $4.35 | -32.38% |